2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations

被引：574

作者：

Genest, Jacques ^{[1
]}

McPherson, Ruth ^{[2
]}

Frohlich, Jiri ^{[3
]}

Anderson, Todd ^{[4
]}

Campbell, Norm ^{[4
]}

Carpentier, Andre ^{[5
]}

Couture, Patrick ^{[6
]}

Dufour, Robert ^{[7
]}

Fodor, George ^{[2
]}

Francis, Gordon A. ^{[3
]}

Grover, Steven ^{[1
]}

Gupta, Milan ^{[8
]}

Hegele, Robert A. ^{[9
]}

Lau, David C. ^{[10
]}

Leiter, Lawrence ^{[11
]}

Lewis, Gary F.

Lonn, Eva ^{[12
]}

Mancini, G. B. John ^{[13
]}

Ng, Dominic ^{[11
]}

Pearson, Glen J. ^{[14
]}

Sniderman, Allan

Stone, James A. ^{[10
]}

Ur, Ehud ^{[13
]}

机构：

[1] McGill Univ, Ctr Hlth, Montreal, PQ H3A 1A1, Canada

[2] Univ Ottawa, Inst Heart, Ottawa, ON, Canada

[3] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada

[4] Libin Cardiovasc Inst Alberta, Calgary, AB, Canada

[5] CHU Sherbrooke, Sherbrooke, PQ J1H 5N4, Canada

[6] CHU Quebec, Quebec City, PQ, Canada

[7] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada

[8] McMaster Univ, Dept Med, Hamilton, ON, Canada

[9] Robarts Res Inst, London, ON N6A 5C1, Canada

[10] Univ Calgary, Calgary, AB, Canada

[11] Univ Toronto, St Michaels Hosp, Toronto, ON M5B 1W8, Canada

[12] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada

[13] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada

[14] Univ Alberta, Edmonton, AB, Canada

来源：

CANADIAN JOURNAL OF CARDIOLOGY | 2009年 / 25卷 / 10期

关键词：

Atherosclerosis; Cardiovascular risk factors; Cholesterol; Coronary artery disease; Dyslipidemia; Lipids; Secondary prevention; DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; INFLAMMATORY-BOWEL-DISEASE; TYPE-2; DIABETES-MELLITUS; FRAMINGHAM RISK SCORE; C-REACTIVE PROTEIN; METABOLIC SYNDROME; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; ARTERY-DISEASE;

D O I：

10.1016/S0828-282X(09)70715-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The present article represents the 2009 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult.

引用

页码：567 / 579

页数：13

共 77 条

[1] The metabolic syndrome - a new worldwide definition
Alberti, KGMM
Zimmet, P
Shaw, J
[J]. LANCET, 2005, 366 (9491) : 1059 - 1062
[2] Comparison of Treatment of Severe High-Density Lipoprotein Cholesterol Deficiency in Men With Daily Atorvastatin (20 mg) Versus Fenofibrate (200 mg) Versus Extended-Release Niacin (2 g)
Alrasadi, Khalid
Awan, Zuhier
Alwaili, Khalid
Rue, Isabelle
Hafiane, Anouar
Krimbou, Larbi
Genest, Jacques
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (10) : 1341 - 1347
[3] Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)
Anand, SS
Yusuf, S
Vuksan, V
Devanesen, S
Teo, KK
Montague, PA
Kelemen, L
Yi, CL
Lonn, E
Gerstein, H
Hegele, RA
McQueen, M
[J]. LANCET, 2000, 356 (9226) : 279 - 284
[4] Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
Baigent, C
Keech, A
Kearney, PM
Blackwell, L
Buck, G
Pollicino, C
Kirby, A
Sourjina, T
Peto, R
Collins, R
Simes, J
[J]. LANCET, 2005, 366 (9493) : 1267 - 1278
[5] Metabolic syndrome associated with HIV and highly active antiretroviral therapy
Barbaro, Giuseppe
Iacobellis, Gialuca
[J]. CURRENT DIABETES REPORTS, 2009, 9 (01) : 37 - 42
[6] HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
Barter, Philip
Gotto, Antonio M.
LaRosa, John C.
Maroni, Jaman
Szarek, Michael
Grundy, Scott M.
Kastelein, John J. P.
Bittner, Vera
Fruchart, Jean-Charles
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (13) : 1301 - 1310
[7] Effects of torcetrapib in patients at high risk for coronary events
Barter, Philip J.
Caulfield, Mark
Eriksson, Mats
Grundy, Scott M.
Kastelein, John J. P.
Komajda, Michel
Lopez-Sendon, Jose
Mosca, Lori
Tardif, Jean-Claude
Waters, David D.
Shear, Charles L.
Revkin, James H.
Buhr, Kevin A.
Fisher, Marian R.
Tall, Alan R.
Brewer, Bryan
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) : 2109 - 2122
[8] Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel
Barter, PJ
Ballantyne, CM
Carmena, R
Cabezas, MC
Chapman, MJ
Couture, P
De Graaf, J
Durrington, PN
Faergeman, O
Frohlich, J
Furberg, CD
Gagne, C
Haffner, SM
Humphries, SE
Jungner, I
Krauss, RM
Kwiterovich, P
Marcovina, S
Packard, CJ
Pearson, TA
Reddy, KS
Rosenson, R
Sarrafzadegan, N
Sniderman, AD
Stalenhoef, AF
Stein, E
Talmud, PJ
Tonkin, AM
Walldius, G
Williams, KMS
[J]. JOURNAL OF INTERNAL MEDICINE, 2006, 259 (03) : 247 - 258
[9] The incidence of arterial thromboembolic diseases in inflammatory bowel disease: A population-based study
Bernstein, Charles N.
Wajda, Andre
Blanchard, James F.
[J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (01) : 41 - 45
[10] Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk
Brown, B. Greg
Zhao, Xue-Qiao
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (8A) : 58B - 62B

← 1 2 3 4 5 6 7 8 →